Learn more about how innovative treatments, including prescription digital therapeutics #PDTs developed on Click’s AI-enabled platform, can enhance the standard of care for patients in Business Insider recent article: businessinsider.com/artificial-int…

Click CEO David Benshoof Klein will be participating in the Tech Tour Mental & Brain Health 2024 meeting to discuss the potential of prescription digital therapeutics ( #PDTs ) in the future of mental health and brain tech.

Learn more: techtour.com/events/2024/5/…

#TTMENTALHEALTH24

Click Therapeutics CEO, David Benshoof Klein, sat down with Gil Bashe of HealthUnaBASHEd Radio Show to discuss the current state of the #PrescriptionDigitalTherapeutics market.

To listen to the full conversation, visit: healthcarenowradio.com/programs/healt… #HealthUnaBASHEd

Click has been included in Built In's 2024 Best Places to Work in the U.S. It is an exciting time to be a part of Click, and we are proud to have cultivated an inclusive and exciting work environment.

Interested in joining our team? Visit: clicktherapeutics.com/careers

#NEWS : The U.S. FDA has granted Breakthrough Device designation to our investigational prescription digital therapeutic (PDT) developed in collaboration with Click Therapeutics® to potentially help treat the negative symptoms of #schizophrenia .
Learn more: bit.ly/3Lqu8RY

We are thrilled to announce that our investigational CT-155 PDT, co-developed with Boehringer Ingelheim to treat the negative symptoms of schizophrenia, has received Breakthrough Device designation from the U.S. FDA.
Read the full release here: clicktherapeutics.com/press/click-th…

We’re pleased to announce that our CEO David Benshoof Klein will present at the 42nd Annual @JPMorgan Healthcare Conference on January 11th at 10:00 am PST.
To request a meeting, please reach out to our team at [email protected] or at [email protected].
#JPM2024

The FDA's new advisory committee and draft guidance for prescription drug use-related software could be game-changers.

As clinical evidence emerges, companies like Click Therapeutics® are poised to make an impact > owy.mn/487rAlz #OWHealth #DigitalHealth #FDA

We are excited to announce that we have secured $20 million in debt financing from HSBC Innovation Banking to help advance Click’s prescription digital therapeutic pipeline.

Read the full press release here: clicktherapeutics.com/press/click-th…

Click Therapeutics will be taking meetings in Munich during the BIO-Europe Conference from November 6th-8th, 2023.

To request a meeting regarding partnership opportunities, please contact [email protected]

We look forward to seeing you!

#BIOEurope #DigitalHealth #DTx

People living with cancer experience multiple accompanying conditions and symptoms that persist during and even after cancer treatment. Click is working to address these gaps in care with the help of #PrescriptionDigitalTherapeutics .
Learn more: clicktherapeutics.com/clinical-trials
#BCAM2023

Our CEO, David Benshoof Klein discussed the value of prescription digital therapeutics as a tool for Pharmacists in providing patient-centric care with Pharmacy Podcast Network

Listen here: pharmacypodcastnetwork.podbean.com/e/digital-ther…

Our Chief Medical Officer, Shaheen E Lakhan, MD, PhD, met with Pharmacy Podcast Network to discuss how PDTs will become part of the standard of care, combining pharmaceutical and digital innovation to empower successful patient journeys.

Listen here: pharmacypodcastnetwork.podbean.com/e/click-therap…

We are proud to announce the launch of our second active randomized clinical trial in migraine for patients receiving CGRP inhibitor therapy, alongside our clinical trial solutions partner Syneos Health. Read the full release here: clicktherapeutics.com/press/click-th…

Our CMO, Shaheen Lakhan, MD, PhD was featured on the #TheHealthcareandHigher #podcast . He discussed how digital therapeutics are breaking the mold in the prescription world by broadening accessibility to proven and personalized solutions. Listen here atchainternational.com/healthcare-and…

This week on the Syneos Health Podcast, our CMO, Dr. Shaheen Lakhan, joins host Jeff Stewart to discuss misconceptions experienced clinicians have about prescription digital therapeutic development. Listen here: syneoshealth.com/insights-hub/s…
#digitalTherapeutics #DigitalHealth

Our team was excited to attend and speak at #2023DTASummit last week, where we had the opportunity to collaborate and engage with the best and brightest minds that are helping to shape the future of #digitalTherapeutics #digitalHealth

Our Chief Strategy Officer, Austin Speier, discussed the evolving field of prescription digital therapeutics and its impact on healthcare on the Syneos Health Podcast.
Tune in for this insightful conversation! #DigitalTherapeutics #BIO2023 #DigitalHealth syneoshealth.com/insights-hub/s…

Our CEO, David B. Klein, calls for prescription #digitaltherapeutics to be held to rigorous clinical and regulatory standards comparable to any approved prescription drug in a recent article on MedCity News Read the full article here: medcitynews.com/2023/05/in-the…

We are committed to help smokers lead a smoke-free life through our validated clinical studies and personalized technology.

To learn more about our smoking cessation program, visit:
clickotine.com

#StayQuitWithClick #WorldNoTobaccoDay